Cetirizine Hydrochloride/Pseudoephedrine Hydrochloride

盐酸西替利嗪/盐酸伪麻黄碱

Report date: 2022/01/14 13:23:58

Base Information

Drug NameCetirizine Hydrochloride/Pseudoephedrine Hydrochloride
Drug Alias NameCetirizine Hydrochloride-Pseudoephedrine Hydrochloride mixt西替利嗪/盐酸伪麻黄碱盐酸西替利嗪盐酸伪麻黄碱Pseudoephedrine Hydrochloride and Cetirizine Hydrochloride盐酸伪麻黄碱/盐酸西替利嗪 +[17] 
ClassificationSmall molecules
Mechanisms of ActionHistamine H1 receptor antagonistsAlpha adrenergic receptor agonists
TargetsHistamine H1 receptorAlpha adrenergic receptor
Therapy Area/IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic, PerennialAsthma
Global Approved IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic, PerennialAsthma
Approved Indications in ChinaAsthma
Original Approved Country/TerritoryUnited States
Original Approved Date2003/04/14
Country/TerritoryUnited StatesMainland China
CombinationsYes Pseudoephedrine HydrochlorideCetirizine Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesUcb
China Registration ClassN/A

Develop Information

Active CompaniesKenvue IncJinling Pharmaceutical Co Ltd Nanjing Jinling Pharmaceutical Factory
Inactive CompaniesN/A
Active IndicationsRhinitis, Allergic, SeasonalRhinitis, Allergic, PerennialAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR01BA52
Related LinksN/A